BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lê MP, Stitou H, Soulie C, Katlama C, Peytavin G. Sialolithiasis in an HIV-1-infected patient treated with atazanavir/ritonavir monotherapy. J Antimicrob Chemother 2013;68:727-9. [PMID: 23118148 DOI: 10.1093/jac/dks433] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
Number Citing Articles
1 Meer S. Human immunodeficiency virus and salivary gland pathology: an update. Oral Surg Oral Med Oral Pathol Oral Radiol 2019;128:52-9. [PMID: 30827854 DOI: 10.1016/j.oooo.2019.01.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
2 Nishijima T, Shimbo T, Komatsu H, Hamada Y, Gatanaga H, Kikuchi Y, Oka S. Cumulative exposure to ritonavir-boosted atazanavir is associated with cholelithiasis in patients with HIV-1 infection. J Antimicrob Chemother 2014;69:1385-9. [PMID: 24379301 DOI: 10.1093/jac/dkt514] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
3 Brooks JK, Jones JL, Price JB. Possible association of sialolithiasis with HIV infection and highly active antiretroviral therapy: A case report. Spec Care Dentist 2020;40:298-302. [DOI: 10.1111/scd.12455] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]